Alnylam Pharmaceuticals (ALNY) Q4 2013 Earnings

6NovConfirmed
Feb 13
May 13
Q3 2013
Q4 2013
-1.43
-1.01
-0.58
-0.16

Details

Expected EPS
N/A
Actual EPS
-0.48
Surprise EPS
-0.48
Surprise Percent
+∞%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.48 per share for Q4 2013.

0 Comments

Share your thoughts